Roussel Uclaf

Calgene Corporation

Other

Aventis Cropsciences Gmbh

Danielle Lando

Charles J Van Assche

Monica Gervais

Jean Michel Bruneau

Toni Alois Voelker

Maud Brandely

Pierre Yves Abecassis

Philippe Riberon

Toni Alols Voelker

Proteins having the activity of saccharose phosphate synthetase (SPS) and a process for obtaining the same.

Sucrose phosphate synthetase (SPS), a preparation method and cDNA therefor, and use of the cDNA for modifying SPS expression in plant cells

Sucrose phosphate synthase (SPS), a process for its preparation, its DNA, and utilization of DNA encoding SPS to modify the expression of SPS in the plant cells are provided. Methods and compositions for producing SPS protein and DNA encoding SPS from a number of sources are provided. Also provided are transgenes comprising DNA encoding SPS and methods for the production of transgenic plant cells and plants which have extra SPS activity, and thus an increased capacity to synthesize sucrose. Transgenic plant cells and plants with the additional SPS activity exhibit altered carbon partitioning, growth and development, and yield under a variety of conditions.

Modification of sucrose phosphate synthase in plants

A cDNA coating for a protein having saccharose phosphate synthetase activity and a vector permitting the expression of a protein having saccharose phosphate synthetase activity under the control of a promoter directing the said expression.

Saccharose phosphate synthetase (SPS), a preparation method and CDNA

A biologically active, non-glycosylated recombinant human Interleukin 2 (R-hIL.sub.2) in reduced form, process for its preparation and method of use.

Administration of non-glycosylated, recombinant human IL.sub.2 in

Non-glycosylated, recombinant human IL .sub.2 in reduced form

A protein having sucrose phosphate synthetase (SPS) activity is isolated from plants, preferably maize. The protein has a molecular weight of 110-130 dK and contains at least one peptide selected from Thv Trp Ile Lys, Try Val Val Glu Leu Ala Arg, Ser Met Pro Pro Ile Trp Ala Glu Val Met Arg, Leu Arg Pro Asp Gln Asp Try Leu Met His Ile Ser His Arg and Trp Ser His Asp Gly Ala Arg. Isolation is carried out by obtaining an extract from the plant by grinding, centrifugation and filtration; enriching the extract in SPS protein by precipitation in an appropriate solvent such as polyethylene glycol, centrifugation and solubilization of the precipitate obtained in a buffer solution; subjecting the protein thus obtained to low pressure anion exchange chromatography, chromatography on heparin Sepharose and high pressure anion exchange chromatography; and purifying the active fractions obtained by passage through two high pressure chromatography columns. Hybridomas and monoclonal antibodies are prepared from an antigen resulting from high pressure anion exchange chromatography above, antibodies directed specifically against SPS are selected and the antibodies are used to purify the SPS obtained previously. Complementary DNA coding for the SPS is prepared and used to modify expression of the SPS in plant cells.

Sucrose phosphate synthetase isolated from maize

Sucrose phosphate synthase (SPS), its process for preparation, its cDNA, and utilization of cDNA to modify the expression of SPS in the plant cells are provided.

Sucrose phosphate synthase (SPS), its process for preparation its cDNA,

A method of treating ovarian cancer in warm-blooded animals comprising intraperitoneally administering to warm-blooded animals by perfusion a recombinant polypeptide of human gamma interferon type with a specific activity at least equal to 1.times.10.sup.7 U/mg in an anti-cancer effective amount.

Treatment method of ovarian cancer using interferon gamma

A method for treating primary cancers of the pleura in humans comprising administering to humans an amount of a polyprotein having human interleukin activity sufficient to treat primary cancers of the pleura.

Treatment of primary cancers of the pleura

A method of treating primary cancers of pleura in warm-blooded animals having said cancers comprising administering to said warm-blooded animals an amount of a polypeptide having human gamma interferon activity sufficient to treat primary cancers of pleura.

Growing community of inventors

Paris, France

Danielle Lando